About
Headquartered in the heart of San Diego’s biotech corridor,
Genece [GEN-iss] is a company with proven technology that delivers the critical answers providers and patients need to improve cancer detection.
Our CAP-accredited, CLIA-certified high-complexity laboratory tests liquid biopsy samples to quickly provide critical answers to physicians and patients. With testing for multiple types of cancer, we aim to improve both patient outcomes and access.
Partnering with GC Genome
GC is the largest conglomerate of healthcare and medical services companies in South Korea. Our partner, GC Genome (GCG), a GC company, has developed and implemented a liquid biopsy multi-cancer early detection test in their clinical laboratory in Seoul.
By forging a strategic partnership, we are leveraging GCG’s extensive clinical expertise and years of product development. This allows us to streamline product development and accelerate delivery of our cancer care solutions.
